The miR-22 and its target, TIP60, were associated with EMT in breast cancer, and the miR-22(high)/TIP60(low) axis was suggested to function as an indicator of breast cancer progression and poor overall survival [75]. This evidence concerns the gene KAT5 and breast cancer.